CannabisNewsBreaks

TuesdayAug 08, 2023 4:29 pm

CannabisNewsBreaks – Sustain SoCal Announced as Host of Eighth Annual Water Solutions Gathering

Sustain SoCal, a nonprofit organization, will host this year’s Water Solutions (“WS8”) event; the in-person event is slated for Aug. 24, 2023, and will be held in Irvine, California. According to the announcement, Water Solutions 8 is a premier gathering that focuses on exploring real-life strategies and innovations for the reuse, desal, stormwater, energy nexus, contamination, investor and policy trends and big data in southern California and the surrounding region. The event agenda features well-known thought leaders and experts who are recognized as specialists in the design and implementation of practical solutions to ensure sufficient and affordable supplies of water in…

Continue Reading

TuesdayAug 08, 2023 4:14 pm

CannabisNewsBreaks — Boston Hemp Inc. Notes ‘Major Milestone’ as THCa Diamonds Available Nationwide

Boston Hemp, a leading provider of premium hemp products, is releasing its highly anticipated THCa diamonds nationwide. A pure and potent form of tetrahydrocannabinolic acid, the THCa diamonds offer powerful therapeutic properties and are an attractive option for individuals looking for a stronger, more effective form of hemp extract. Calling the release of the THCa diamonds a “major milestone,” the company noted that the product is available through nationwide distribution; specific purchase locations can be found on the company website. Boston Hemp makes its THCa diamonds from the highest-quality hemp plants, which are grown using sustainable, organic farming practices and…

Continue Reading

ThursdayAug 03, 2023 3:12 pm

CannabisNewsBreaks — Green Label Summit 2023 to Showcase Insights and Innovations Shaping the Future of Cannabis

The highly-anticipated Green Label Summit 2023, hosted by Jotia Group, is set to shine in the shimmering lights of Las Vegas on Sept. 13 - 14 at The Expo, World Market Center. The event is designed to deliver an unparalleled platform for dynamic discussions and visionary insights into the ever-evolving cannabis industry. The summit will feature the Psychedelic Horizons Forum, captivating sessions and masterclasses, with a special emphasis on the future of cannabis. Throughout the event, experts will share invaluable market predictions and insights into medical advancements, product development, evolving regulations, consumer choices, tourism, cultivation and growing green, and cutting-edge…

Continue Reading

WednesdayAug 02, 2023 1:26 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Designing Human Clinical Study of DehydraTECH-CBD for Weight Loss, Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today reported its intention to conduct a human clinical study to examine DehydraTECH-CBD for purposes of diabetes control and weight loss. Lexaria previously announced that, in its pre-clinical diabetes study DIAB-A22-1 in obese diabetic-conditioned animals, DehydraTECH-CBD achieved each of the following: lowered blood glucose levels by 19.9%; lowered overall body weight by 7% sustained over eight weeks; statistically significant increase in locomotor activity; lowered triglyceride levels by more than 25%; and lowered blood urea nitrogen levels by 27.9%. As a result of the very successful pre-clinical results, Lexaria…

Continue Reading

WednesdayAug 02, 2023 1:04 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Expands Phase 2 Trial to Add New Site

IGC Pharma (NYSE American: IGC) today announced the addition of an important trial site at the University of Puerto Rico network as an expansion of its ongoing phase 2 clinical trial investigating lead drug asset, IGC-AD1, as a treatment for lowering agitation in patients with Alzheimer’s disease. According to clinicaltrials.gov, IGC-AD1 is the only natural THC-based investigational drug undergoing FDA trials. The therapy relies on low doses of THC and another compound as pharmaceutical active agents for the treatment of Alzheimer’s and, in pre-clinical and phase 1 studies, has shown the potential to be effective in ameliorating Aβ plaques and…

Continue Reading

FridayJul 28, 2023 12:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has incorporated a new wholly owned subsidiary: Lexaria Nutraceutical Corp., or LEXX Nutra. According to the announcement, LEXX Nutra was established to support Lexaria’s overall strategy of maximizing the potential for its patented DehydraTECH(TM) technology in a variety of markets. The company issued an exclusive perpetual license to LEXX Nutra, giving the new subsidiary rights to utilize, or sublicense the use of, DehydraTECH in an array of ways, including creating consumer packaged goods (“CPG”) and/or intermediate ingredients composed of any molecule except those associated with nicotine or cannabis. LEXX Nutra…

Continue Reading

FridayJul 21, 2023 11:31 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that Jerry Griffin, VP of Sales and Marketing for InMed’s subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market, will be participating in a fireside chat with Water Tower Research on July 25, 2023, at 2:00 p.m. ET. The event is open for all investors with topics that include an overview of BayMedica, its competitive environment and upcoming catalysts, as well as the market dynamics of rare…

Continue Reading

ThursdayJul 20, 2023 12:04 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today provided a commercial and manufacturing update on its subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market. Among the highlights, the company reported a 123% quarter-over-quarter increase in revenues. “We are very encouraged to see another strong quarter with (unaudited) revenues in excess of $2.3M, representing our third consecutive quarter with significant revenue growth,” said Eric A. Adams, InMed’s president and CEO. “As demand for minor cannabinoids continues to increase, we…

Continue Reading

WednesdayJul 19, 2023 12:03 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches. The company’s superior DehydraTECH processing and sublingual compositions have now been recognized through exceptional scientific study results as well as…

Continue Reading

TuesdayJul 18, 2023 1:21 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to have six posters accepted for presentation at AAIC 2023, a prestigious meeting of leading Alzheimer’s disease experts and pharmaceutical innovators,” said Ram Mukunda, CEO of IGC. “The data being presented at AAIC from our phase 1 clinical trial of IGC-AD1 demonstrates the positive impact of…

Continue Reading